Transcription of CAP Cancer Protocol Urinary Bladder
{{id}} {{{paragraph}}}
Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder Version: UrinaryBladder Protocol Posting Date: June 2017 Includes pTNM requirements from the 8th Edition, AJCC Staging Manual For accreditation purposes, this Protocol should be used for the following procedures AND tumor types: Procedure Description Cystectomy Includes specimens designated partial, total or radical cystectomy, radical cystoprostatectomy (for Bladder Cancer ), and anterior exenterations Tumor Type Description Carcinomas Includes invasive carcinomas of the Urinary tract, including urothelial carcinoma and its morphological variants (squamous cell carcinoma, adenocarcinoma, M llerian carcinoma, neuroendocrine carcinoma, and sarcomatoid carcinoma)# # This Protocol is recommended for reporting noninvasive urothelial tumors (papillary and flat), but it is not required for accreditation purposes. This Protocol is NOT required for accreditation purposes for the following: Procedure Biopsy, transurethral resection of the Bladder tumor (TURBT),# or enucleations Primary resection specimen with no residual Cancer (eg, following neoadjuvant therapy) Cytologic specimens # Transurethral resection of a Bladder tumor is NOT considered to be the definitive resection specimen, even though the entire Cancer may be removed.
Protocol for the Examination of Specimens From Patients With Carcinoma of the Urinary Bladder . Version: UrinaryBladder 4.0.1.0 Protocol Posting Date: June 2017 Includes pTNM requirements from the 8th Edition, AJCC Staging Manual. For accreditation purposes, this protocol should be used for the following procedures AND tumor types:
Domain:
Source:
Link to this page:
Please notify us if you found a problem with this document:
{{id}} {{{paragraph}}}